Story
Netskope Insiders Acquire $7.5 Million in Stock Amid Flurry of Tech Executive Sales

Insiders at Netskope Inc., including a director and a major institutional shareholder, purchased a combined total of more than $7.5 million in company stock, according to regulatory filings disclosed Tuesday. The substantial buying activity provides a sharp contrast to a wave of selling by executives across several other major technology companies.
Significant Insider Buys
Two separate parties at Netskope reported large acquisitions of Class A Common Stock. The purchases were made on July 10, 2026, at weighted average prices between $12.255 and $12.4214 per share.
- William J.G. Griffith, a director and ten percent owner, acquired 306,399 shares for approximately $3.77 million.
- ICONIQ Strategic Partners VIII Holdings, L.P., an affiliated ten percent owner, also purchased shares for a total of approximately $3.77 million.
Other notable insider buying activity disclosed Tuesday included smaller purchases at DLH Holdings Corp. (DLHC) by a significant shareholder, Peoples Financial Corp (PFBX) by investment firm Stilwell Value LLC, and Butler National Corp (BUKS) by a director.
Tech Executives Divest Holdings
In contrast to the buying at Netskope, executives at several large technology and healthcare firms sold significant blocks of stock. Many of these sales were conducted under pre-arranged Rule 10b5-1 trading plans, which allow insiders to sell shares at predetermined times to avoid accusations of trading on non-public information.
AdMajor sales included:
- Arista Networks, Inc. (ANET): CEO and Chairperson Jayshree Ullal sold 234,578 shares for a total of approximately $43.9 million.
- Broadcom Inc. (AVGO): The chief legal and corporate affairs officer, Mark David Brazeal, sold 25,000 shares for over $10 million.
- Everpure, Inc.: Chief Visionary Officer John Colgrove sold 100,000 shares through trusts for nearly $8 million.
- Lam Research Corp. (LRCX): Director Abhijit Y. Talwalkar sold 18,282 shares for approximately $6.1 million.
- Alignment Healthcare, Inc. (ALHC): Chief Executive Officer John E. Kao sold 298,000 shares for a total of $5.92 million.
Market Interpretation
Investors closely monitor insider transactions as a potential indicator of executive sentiment. Substantial open-market purchases, like those at Netskope, are often interpreted as a bullish signal, suggesting that company leaders believe the stock's future prospects are strong.
Conversely, insider sales are more complex. While they can precede a stock's decline, they do not necessarily signal a lack of confidence. Insiders often sell shares for reasons unrelated to company performance, such as for personal financial planning, portfolio diversification, or to cover tax obligations. The use of Rule 10b5-1 plans in many of Tuesday's largest sales underscores this distinction.
Read next
More on Stocks
FTC Orders Walmart, Uber, Delta to Disclose Data on Personalized Pricing
The U.S. Federal Trade Commission is demanding nine major companies, including leading retail, travel, and gig economy firms, to provide information on how they use consumer data for setting individual prices and wages.

Google Launches Gemini 4 Carbon AI Model to Bolster Cybersecurity Capabilities
Alphabet's Google has unveiled Gemini 4 Carbon, its latest AI model specifically designed for advanced cybersecurity tasks like vulnerability detection and secure code generation. The launch escalates competition with rivals OpenAI and Anthropic in the enterprise AI market.

Oracle Shares Surge After Unveiling $225 Billion Revenue Target for 2030
Oracle stock rose sharply after the company presented a long-term financial outlook targeting at least $225 billion in annual revenue by fiscal 2030, driven by its expanding AI infrastructure business.

DOJ Scrutinizes Nvidia's $12.9B Hugging Face Deal Amid Broader Antitrust Probe, Sources Say
The U.S. Department of Justice is reportedly examining Nvidia's planned $12.93 billion acquisition of AI platform Hugging Face as part of a wider, ongoing antitrust investigation into the chipmaker's market conduct.